miR-9 is known to target important ECM proteins (fibronectin [FN], collagen [COL]) and their regulator (TGFβ1), multiple inflammatory mediators (IL-6, IL-1β, TNFα) and NF-κB—key molecules in DCM [43]. Here, FN1 is linked to familial dilated cardiomyopathy.